Diagnosing CTE: What a Neurologist Wants You to Know

As the well-known — but little understood — brain disease cycles in and out of the news, a Michigan Medicine specialist explains the latest science.

3:15 PM

Author | Kevin Joy

For years, the lasting effects of sports-related head injuries such as chronic traumatic encephalopathy, or CTE, have been a point of conversation and concern. News stories and films put the issue before a wide audience.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

And it was recently revisited when retired NFL star Brett Favre revealed in a television interview that he has likely sustained "thousands of concussions" during his 19-year professional career — and that he thinks he may have "early stages" of CTE as a result.

The neurodegenerative disease, believed to be caused by repetitive brain trauma, is marked by progressive issues that include cognitive impairment, anxiety, depression and impulsive behavior, among other things.

But while Favre says he may have signs of CTE (he spoke about misplacing his keys and eyeglasses in the interview), there's no way to know for sure right now, says Matthew Lorincz, M.D., Ph.D., associate professor of neurology at the University of Michigan.  

That's because CTE can only be diagnosed after death. Doctors must conduct an autopsy to look for signs of brain tissue degeneration and a buildup of abnormal tau proteins.

"CTE is not a clinical diagnosis; there are no MRI or CT scans we can order," says Lorincz, noting that a recent study analyzing spinal fluid to detect CTE has a long way to go before approval and use.

"There is no current way to diagnose CTE in a living person, despite what you might hear."

TES: A new diagnostic approach

That knowledge gap has left potentially affected patients searching for help and answers. After all, the onset of symptoms can occur years or decades after injuries.

SEE ALSO: What Happens When You Get a Concussion

Michigan Medicine researchers in 2016 developed a diagnostic framework for a new clinical diagnosis, traumatic encephalopathy syndrome (TES). Related to a history of concussions, TES is marked by characteristics seen in CTE: problems with memory, mood and motor function.

To avoid a false-positive diagnosis, other comorbid symptoms (such as sleep disorders or substance abuse) should be considered and treated — and a patient's symptoms must persist for at least two years. They also need to have a history of concussions, and other neurologic diseases need to be ruled out.

The concept of TES is new. And the relationship between CTE and TES is unknown.  

There is no known cure, but the TES criteria were introduced to help determine when targeted intervention might be used to preserve quality of life and slow potential decline in at-risk patients.

"Some treatments, although symptomatic, can have a really significant impact on a person's life," Lorincz says. "These might include physical therapy for imbalance, developing cognitive or thinking strategies and pharmacological therapies for mood disorders."

CTE risks vary by sport, length of play

Lorincz, who is also co-director of Michigan NeuroSport, notes that wider awareness of CTE and its relation to sports has sparked important dialogue about athlete safety.

"Football and collision sports, when played over long periods of time, have the potential to be dangerous in many different ways," he says. "There's definitely an amount of repetitive trauma that is going to cause a higher risk of brain damage when you look under the microscope."

The risks, however, are varied in many ways.

Those who compete recreationally or with a school team don't face the same hazards as professional boxers or hockey players that absorb frequent blows for years, Lorincz notes.

SEE ALSO: 3 Ways Athletic Trainers Help Competitors Perform Their Best

Regardless of their status, anyone concerned about brain damage from past game play should consult a neurologist, even if the collisions happened long ago, he adds.

"It's important to look at the history of traumatic brain injury — the number of concussions and sub-concussive blows sustained routinely throughout some sport," Lorincz says.

"I think more people are interested in trying to understand the risks and, hopefully, how to reduce them."

For concussion care or a second opinion, contact the Michigan NeuroSport clinic at 734-930-7400 or click here.


More Articles About:

Brain Health Brain Injury Sports Injury Neurological (Brain) Conditions
Health Lab word mark overlaying blue cells

Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

couple sitting on bench black and white kissing on cheek
Health Lab

Helping an employee-turned-patient overcome a brain tumor

A patient with a brain tumor talks about their experience being an employee receiving care at Michigan Medicine.
wine being poured into glass
Health Lab

Psychoactive substances and adverse side effects for patients with multiple sclerosis

Psychoactive substances can give immediate relief to people living with multiple sclerosis, but some come with adverse side effects. Research led by University of Michigan Health looks at the positive and negative impacts of using psychoactive substances to manage symptoms.
Nurse or home caregiver and senior woman holding hands at home
Health Lab

Severe strokes linked to 5 times higher dementia risk

As stroke severity increases, the risk of progressive cognitive decline and dementia substantially rises, according to a national study led by Michigan Medicine researchers.
brain image in blue grainy white background with yellow floating circles and
Health Lab

Itaconate identified as a new target for pediatric brain tumors called ependymomas

University of Michigan researchers have found that a specific molecule called itaconate drives the development of ependymomas, a pediatric brain tumor. Their findings can help future drug development for children with this type of malignant brain tumor.
black background and white specs forming a brain floating with light ring under the brain
Health Lab

An AI model that can read and diagnose a brain MRI in seconds

An AI-powered model developed at University of Michigan can read a brain MRI and diagnose a person in seconds, new research finds.
The illustration depicts a brain with a glioma and its digital twin.
Health Lab

Brain cancer digital twin predicts treatment outcomes

A machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the University of Michigan, could help doctors discover which treatment strategies are most likely to be effective against individual cases of glioma.